StreetAlpha
13F holdings · Q3 2026

General Atlantic

New York, NY · files as General Atlantic, L.P.
Know the moment General Atlantic filesYou follow General Atlantic An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1017645

General Atlantic reported 12 stocks worth $2.5B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are DLO (20.4%), CHYM (20.3%) and LFTO (16.1%). Compared with Q2 2026, the fund opened new positions in KRSA, added to RSKD, trimmed DLO, CHYM and XP and sold out of RVMD.

Latest filing: what General Atlantic did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
1 new1 added4 trimmed1 sold outBought about $85.8M · sold about $475M
New 1
Added 1
Trimmed 4
  • PHVS−$155M−75%
  • DLO−$135M−21%
  • CHYM−$62.2M−11%
  • XP−$54.7M−13%
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$2.5B−14.7% vs last quarter
Stocks held121 new · 1 sold out
Top 5 weight82.8%very concentrated
Turnover23%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
DLO
Dlocal Ltd Class A Com
$507M20.4%36.8M−9.8M (−21%)8 of 8
2
CHYM
Chime Finl Inc
$504M20.3%18.9M−2.3M (−11%)6 of 8
3
LFTO
Liftoff Mobile Inc Com
$400M16.1%25.3MNo change2 of 8
4
XP
XP Inc
$377M15.2%18M−2.6M (−13%)8 of 8
5
ALKT
Alkami Technology Inc
$265M10.7%19.4MNo change8 of 8
6
SPTX
Seaport Therapeutics Inc
$123M5.0%6.1MNo change2 of 8
7
RSKD
Riskified Ltd
$84.2M3.4%10.6M+5.3M (+100%)8 of 8
8
NRIX
Nurix Therapeutics Inc
$71.9M2.9%3MNo change4 of 8
9
PHVS
Pharvaris N V
$52.4M2.1%1.7M−4.9M (−75%)8 of 8
10
PBLS
Parabilis Medicines Inc Com
$49.7M2.0%1.5MNo change2 of 8
🔒 2 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
RVMD
Revolution Medicines Inc
$67M358K

Reported value

last 8 quarters
$2.8BQ4 '24
$3BQ1 '25
$3.6BQ2 '25
$3.3BQ3 '25
$2.9BQ4 '25
$2.1BQ1 '26
$2.9BQ2 '26
$2.5BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

General Atlantic 13F FAQ

What does General Atlantic own?

General Atlantic reported 12 stocks worth $2.5B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are DLO (20.4%), CHYM (20.3%) and LFTO (16.1%). The table above lists every position in the filing (the top 10 without an account).

What did General Atlantic buy and sell in Q3 2026?

Compared with Q2 2026: 1 new positions, 1 added to, 4 trimmed and 1 sold out. New positions include KRSA. It sold all of RVMD.

When will General Atlantic file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is General Atlantic's portfolio worth?

The Q3 2026 filing reports $2.5B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.